BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35111054)

  • 1. Role of miRNA-671-5p in Mediating Wnt/β-Catenin-Triggered Podocyte Injury.
    Wang C; Liu J; Zhang X; Chen Q; Bai X; Hong X; Zhou L; Liu Y
    Front Pharmacol; 2021; 12():784489. PubMed ID: 35111054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
    Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
    FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.
    Zhou L; Liu Y
    Nat Rev Nephrol; 2015 Sep; 11(9):535-45. PubMed ID: 26055352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
    Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
    Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.
    Zhou L; Li Y; He W; Zhou D; Tan RJ; Nie J; Hou FF; Liu Y
    J Am Soc Nephrol; 2015 Mar; 26(3):677-91. PubMed ID: 25071087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR-143/145 cluster induced by TGF-β1 suppresses Wilms' tumor 1 expression in cultured human podocytes.
    Tabei A; Sakairi T; Hamatani H; Ohishi Y; Watanabe M; Nakasatomi M; Ikeuchi H; Kaneko Y; Kopp JB; Hiromura K
    Am J Physiol Renal Physiol; 2023 Jul; 325(1):F121-F133. PubMed ID: 37167274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
    Jing Z; Wei-jie Y; Yi-Feng ZG
    Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy.
    Wan J; Hou X; Zhou Z; Geng J; Tian J; Bai X; Nie J
    Free Radic Biol Med; 2017 Jul; 108():280-299. PubMed ID: 28315733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.
    Mo H; Wu Q; Miao J; Luo C; Hong X; Wang Y; Tang L; Hou FF; Liu Y; Zhou L
    Antioxid Redox Signal; 2017 Aug; 27(6):345-362. PubMed ID: 27960539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria.
    Zhou L; Chen X; Lu M; Wu Q; Yuan Q; Hu C; Miao J; Zhang Y; Li H; Hou FF; Nie J; Liu Y
    Kidney Int; 2019 Apr; 95(4):830-845. PubMed ID: 30770219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
    Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
    J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractalkine is Involved in Lipopolysaccharide-Induced Podocyte Injury through the Wnt/β-Catenin Pathway in an Acute Kidney Injury Mouse Model.
    Senouthai S; Wang J; Fu D; You Y
    Inflammation; 2019 Aug; 42(4):1287-1300. PubMed ID: 30919150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
    Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X
    Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.
    Wang D; Dai C; Li Y; Liu Y
    Kidney Int; 2011 Dec; 80(11):1159-1169. PubMed ID: 21832980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling.
    Zhang H; Ren R; Du J; Sun T; Wang P; Kang P
    Kidney Blood Press Res; 2017; 42(5):794-803. PubMed ID: 29069662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
    He W; Kang YS; Dai C; Liu Y
    J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease.
    Chen X; Xiao J; Tao D; Liang Y; Chen S; Shen L; Li S; Zheng Z; Zeng Y; Luo C; Peng F; Long H
    Transl Res; 2024 Apr; 266():68-83. PubMed ID: 37995969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1.
    Li TS; Chen L; Wang SC; Yang YZ; Xu HJ; Gu HM; Zhao XJ; Dong P; Pan Y; Shang ZQ; Zhang XQ; Kong LD
    Biochem Pharmacol; 2019 Aug; 166():139-152. PubMed ID: 31085161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
    Guo N; Guo J; Su D
    Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin.
    Alquraishi M; Chahed S; Alani D; Puckett DL; Dowker PD; Hubbard K; Zhao Y; Kim JY; Nodit L; Fatima H; Donohoe D; Voy B; Chowanadisai W; Bettaieb A
    Cell Commun Signal; 2022 May; 20(1):76. PubMed ID: 35637461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.